MOJ Header

Current Issue - November 2024, Volume 18, Issue No. 3

Official Journal of Malaysian Orthopaedic Association and ASEAN Orthopaedic Association

Dabigatran-induced Enterococcus Necrotizing Fasciitis in Medically Unfit Patient with Successful Conservative Treatment Outcome: A Case Report

References

  1. Gómez-Outes A, Terleira-Fernández AI, Suárez-Gea ML, Vargas-Castrillón E. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. BMJ. 2012; 344: e3675. doi: 10.1136/bmj.e3675
  2. Yahav D, Duskin-Bitan H, Eliakim-Raz N, Ben-Zvi H, Shaked H, et al. Monomicrobial necrotizing fasciitis in a single center: the emergence of Gram-negative bacteria as a common pathogen. Int J Infect Dis. 2014; 28: 13-6. doi: 10.1016/j.ijid.2014.05.024
  3. Schindler M, Baertl S, Walter N, Lang S, Szymski D, Alt V, et al. Retrospective analysis of mortality and quality of life after hip disarticulation or hemipelvectomy: a report on 15 patients. Arch Orthop Trauma Surg. 2023; 143(8): 4943-9. doi: 10.1007/s00402-023-04783-4
  4. Doyle DJ, Hendrix JM, Garmon EH. American Society of Anesthesiologists Classification. [Updated 2023 Aug 17]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. https://www.ncbi.nlm.nih.gov/books/NBK441940/
  5. Smilowitz NR, Berger JS. Perioperative Cardiovascular Risk Assessment and Management for Noncardiac Surgery: A Review. JAMA. 2020; 324(3): 279-90. doi: 10.1001/jama.2020.7840

Abstract   |   Reference

MOJ footer

About Us

The Malaysian Orthopaedic Journal is a peer-reviewed journal that is published three times a year in both print and electronic online version. The purpose of this journal is to publish original research studies, evaluation of current practices and case reports in various subspecialties of orthopaedics and traumatology, as well as associated fields like basic science, biomedical engineering, rehabilitation medicine and nursing.

Keep in Touch

creative-commons License